Skip to main content

Table 2 Characteristics of studies included in out meta-analysis

From: Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis

Author

Years Included

Region

No.

Treatment Characteristic

Pathology

Depth of Invasion

Staining

Indicator (No.)

Including Statistics

NOS Scores

Jia (2016) [11]

2010-2015

China

93

Esophagectomy and lymphadenectomy

SCC/Others

M1-SM3

NM

LVI(28)

LNM

5

Sepesi (2010) [12]

2000-2008

USA

54

Esophagectomy and lymphadenectomy

AD

SM

NM

LVI(7)

LNM

5

Leggett (2015) [7]

1995-2011

USA

269

EMR followed by ablative techniques

AD

LP-SM

H&E

LVI(53)

OS

6

Huh (2017) [13]

1996-2015

Korea

275

187 Esophagectomy and 88 ER (Esophagectomy or ER)

SCC

M-SM

H&E

LVI(36)

LNM

6

Zhou (2016) [14]

2008-2015

China

498

Esophagectomy with lymphadenectomy

SCC

M1-SM3

H&E/IHC

LI(16/412)

LNM

7

Moon (2014) [15]

2009-2012

Korea

104

Esophagectomy with lymphadenectomy

SCC

M1-SM3

H&E

LVI(13)

LNM

6

Mitobe (2013) [16]

1990-2009

Japan

110

106 Esophagectomy with lymphadenectomy, 4 esophagectomy follwed ER and lymphadenectomy

SCC

LP-SM3

IHC

LI(42)

LNM

6

Nentwich (2014) [17]

1994-2009

Germany

67

Esophagectomy

SCC/AD

SM

NM

LI(16/61)

LNM

5

Raja (2011) [18]

1983-2010

USA

120

Esophagectomy

SCC/AD

SM

NM

LVI(26)

LNM/OS

5

Nakajima (2002) [19]

1985-1995

Japan

84

Esophagectomy with lymphadenectomy

SCC

SM

IHC

LI(60)

LNM

6

Choi (2011) [20]

1991-2009

Korea

190

Esophagectomy with lymphadenectomy

SCC

M1-SM3

H&E

LVI(39)

LNM

7

Tajima (2000) [21]

1968-1996

Japan

240

Esophagectomy with lymphadenectomy

SCC

LP-SM

H&E

LI(39/186)

LNM

6

Chiba (2010) [22]

1992-2008

Japan

110

107 underwent esophagectomy, 3 patients underwent ER followed esophagectomy

SCC

M-SM

IHC

LI(46)

LNM

6

Yamashina (2013) [8]

1995-2010

Japan

402

EMR or ESD, some patients received surgery after ER

SCC

EP-SM2

NM

LVI(33)

OS

5

Xue (2012) [23]

1990-2004

China

271

Esophagectomy

SCC

M2-SM3

IHC

LI(51)

LNM

7

Ancona (2008) [24]

1980-2006

Italy

98

Esophagectomy with lymphadenectomy

SCC/AD

M1-SM3

NM

LI(34)

LNM

5

Li (2013) [25]

2006-2011

China

189

Esophagectomy with lymphadenectomy

SCC

M1-SM3

NM

LVI(22)

LNM

5

Qi (2016) [26]

2009-2014

China

258

Esophagectomy with lymphadenectomy

SCC

SM

H&E

LVI(18)

LNM/OS

6

Wang (2016) [27]

2002-2014

Japan

598

Esophagectomy with lymphadenectomy

SCC

M-SM

H&E/IHC

LI(62/228)

LNM

6

Kim (2008) [28]

1994-2006

Korea

200

Esophagectomy with lymphadenectomy

SCC/AD

M-SM

NM

LI(33)

LNM

5

Tanaka (2014) [9]

1988-2010

Japan

145

Esophagectomy with lymphadenectomy

SCC

SM1-SM3

NM

LVI(84)

OS

5

Zhuge (2018) [29]

2006-2016

China

175

Esophagectomy with lymphadenectomy

SCC

SM1-SM3

NM

LVI(32)

LNM

6

Xue (2018) [10]

1990-2004

China

199

Esophagectomy with lymphadenectomy

SCC

M2-SM3

IHC

LVI(27)

OS

6

  1. LVI Lymphovascular Invasion, LI Lymphatic invasion
  2. ER Endoscopic resection, EMR Endoscopic mucosal resection, ESD Endoscopic submucosal dissection
  3. SCC Squamous cell carcinoma, AD Adenocarcinoma, OS Overall survival
  4. EP Epithelium, M Mucosa, SM Submucosa, LP Lamina propria, NM Not mentioned
  5. H&E Hematoxylin-eosin, IHC Immunohistochemical